Welsh Development Bank backs medical technology company with £500,000 financing
**Amotio's Revolutionary Surgical Technology Aims to Transform Joint Replacement Procedures**
Amotio, a Cwmbran-based medtech business, has made significant strides in the medical field with its innovative technology. The company has developed a high-precision surgical cutting device and guide technology using 3D printing, designed to streamline the process of removing surgical cement during hip revision surgeries [1].
This groundbreaking invention promises to improve surgical outcomes and accelerate recovery for patients undergoing joint surgeries, particularly those requiring replacement of an earlier prosthesis [1]. Currently, the removal of old surgical cement can be a lengthy and complex process, often resulting in prolonged rehabilitation periods of up to 12–15 weeks before patients can bear weight on the joint again [1].
Amotio's device is designed to provide tailored, high-precision tools that can make the cement removal process faster and less invasive, reducing surgical trauma [1]. By minimising damage to surrounding bone and tissue, the technology aims to potentially reduce complications and shorten recovery and rehabilitation times, enabling patients to regain mobility sooner and enhancing their overall post-operative experience [1].
The potential impact of this innovation is immense, with the ability to make joint revision surgeries safer and more efficient, thereby improving quality of care and patient outcomes globally [1]. Amotio's recent £810,000 investment, led by the Development Bank of Wales, will support the company in further developing its product, leading to pre-clinical testing and regulatory approval [1].
The Development Bank of Wales, a key player in unlocking ambition and driving long-term sustainable growth in Wales, led the funding round with a £500,000 equity investment [2]. NLC Health Ventures, with roots in the Netherlands and Wales, and Orthopaedic Research UK (ORUK) also participated in the funding round, investing £210,000 and £100,000 respectively [3].
The partners are excited about Amotio's technology's potential to make the next round of evaluation and testing [4]. NLC Health Ventures sees Amotio's venture as an example of the healthcare innovation they aim to support through their Health Impact Fund [5]. The Wales Technology Seed Fund, which provides equity investment to Welsh tech businesses at the proof of concept stage, also supported Amotio [6].
The success of ventures like Amotio is a testament to the alignment of clinical expertise, entrepreneurial vision, and strategic partnerships [7]. The Development Bank of Wales works hard to identify and nurture co-investment alongside specialist funders like NLC Health Ventures and ORUK [8].
Amotio's technology has applications for hip operations and aims to be applicable to all major joint surgeries. The company plans to target medical markets in the US, Europe, and Asia-Pacific, with the funding being used to advance technology for better post-operative care and recovery times for joint-surgery patients.
- Amotio's innovative digital health technology, which utilizes 3D printing, offers a potential solution for improving the removal of surgical cement during hip revision surgeries, streamlining the process and accelerating patient recovery.
- Science and technology play a significant role in Amotio's business, as they develop high-precision tools that not only make cement removal faster but also less invasive, reducing surgical trauma and shortening recovery times.
- The implications of Amotio's technology in the field of digital health extend beyond hip surgeries, aiming to revolutionize major joint replacement procedures worldwide, ultimately enhancing health and wellness outcomes for patients.
- In addition to the Development Bank of Wales, NLC Health Ventures, and Orthopaedic Research UK (ORUK), Amotio's technology has attracted the interest of investors, as it holds promise for improving medical conditions and the overall post-operative experience for patients.
- The financing secured by Amotio from various sources, including venture capital, business partnerships, and government funding, underscores the importance of finance and investing in the development and growth of technology-driven businesses focused on improving health and fitness.
